Fidelity SPDR Advertisement
Home > Boards > US OTC > Miscellaneous >

BioNeutral Group, Inc. (BONU)

BONU RSS Feed
Add BONU Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator stock_MD
Search This Board:
Last Post: 10/19/2014 7:27:34 PM - Followers: 193 - Board type: Free - Posts Today: 0



http://www.otcmarkets.com/stock/BONU/quote
http://www.otcmarkets.com/stock/BONU/company-info
 

Executive Interview: BioNeutral Group CEO Mark Lowenthal
Mar 5, 2014 8:57 AM | about stocks: BONU

My executive Q & A series has been going very well. I've interviewed some great CEO's in the Small and microcap arenas. Earlier this week I was fortunate enough to have a chance to site down with Mark Lowenthal, CEO of Bioneutral Group Inc. This company was one that I had reported on a few months ago and have been following since mid November of 2013. It seems like the company has just started to build in the 2014 year and after having had the chance to discuss BONU with the company's CEO, I feel that this will be something that I'll continue to follow throughout the year:

Executive Interview with BioNeutral Group CEO Mark Lowenthal

1. In a few words, can you explain what the company does or is planning to do?

Over the last seven years our Company has developed, tested and is now in the process of commercially introducing a series of state of the art and highly competitive sterilization and bioneutralizer products (products that kill micro-organisms on surfaces and eliminate odors in the air at the cellular level). The products have wide applications in various health and life science segments (acute and long-term care, veterinary care, first response, laboratory research, pharma manufacturing), and in industrial segments (janitorial, sanitation, mold remediation, hospitality), both here at home and abroad. They also have substantial applications across various government and consumer markets as well.

With our testing substantially performed as of late 2012, we began 2013 by first accessing the various marketplaces, then developed a focused sales plan, and finally in the later part of the year began to engage independent sales agents, i.e. independent sales groups and distributors.

Overall we've found the markets extremely receptive, and beginning in 2014 we now believe we are finally beginning to be in a position to leverage our technology. To date we have been severely hampered by being undercapitalized and lacking the resources with which to do this.

2. What Direction do you see your industry headed toward?

There is a continually growing movement on a worldwide basis towards higher standards of sterility and high-level disinfection across a wide variety of market segments which we plan to engage in. In this respect, as a high quality and highly efficacious supplier we have high expectations.

3. What are the key risks the company faces right now?

We feel our chief constraint is our access is to capital. Like most small companies, locating cost effective sources of capital can be (and in the past has proven to be) somewhat tricky. However I will say we are making progress in that area and as things stand currently, I feel our prospects have improved.

4. What projects are you currently looking to begin and/or complete?

We are currently in the process of negotiating a supply agreement and a private label transaction with two major market distributors for coverage both here at home and abroad. In addition, we are also in discussions with a major distributor for a key market segment, and we are close to an agreement to begin consumer testing our Ogiene products overseas.

5. What are the current challenges you're facing that could prevent or slow progress from this/these project(s)?

As mentioned above, access to capital.

6. If all goes as planned, how much revenue does the company anticipate generating from this/these project(s)?

We are in the early stages of commercialization and in the process of collecting new market data all the time, and that being said, over the next five years or so my goal is to have the Company generate sales in the $150,000,000 range.

7. How are you currently marketing your product/brand?

By engaging with firms for supply agreements, distribution agreements, private label transactions and independent sales groups.

8. Where do you think the most significant growth will occur for the company over the next 3-6months?

Four key market segments, laboratory research, pharmaceutical and compound manufacturing, janitorial/sanitation and mold remediation

9. You're the CEO of a small cap company. What is the major discerning factor that sets the company apart from the rest and gives you a competitive advantage?

Our proprietary combinational chemistry that makes up our technology; which is highly effective, highly competitive and cost effective.

10. What are you doing to capitalize on the company's strengths and minimize the company's weakness?

We are actively engaged in micro financial markets and are accessing capital there to finance much of our operations and plan to continue to do so.

11. Are you self-funding your projects or do you work with funding sources as a means for operational cash flow?

Our goal is to become financially self-sufficient through our operations as soon as possible. At the current time we are working with a few lending sources.

12. Is there anything that shareholders should know about you personally?

I am a highly trained and fairly successful professional manager. Shareholders can find my bio on line. I am heavily invested in the company, and as such am committed to its success.

It was a pleasure speaking with Mr. Lowenthal and I would like to thank him for his time. Having had the opportunity to discuss several specific topics sheds more light on the company's direction for the new year and even beyond. Until next time,







http://bioneutral.com/Home/Page/products-ygiene 




 

https://www.spectrasan.com/rokdownloads/sales_materials/ygiene-sell-sheet.pdf






http://bioneutral.com/Home/Page/products-ogiene





http://spectrasan.com/rokdownloads/sales_materials/ogiene-sell-sheet.pdf




The Importance about Spectrasan:

Ygiene and Ogiene from BONU is listed as the top products on the Spectrasan website:

Ygiene and Ogiene from BONU is listed as the top products on the Spectrasan website:
 

http://spectrasan.com/
 
Read below from some older news to possibly link an affiliation:

Quote:

http://www.prnewswire.com/news-releases/north-canton-company-fights-against-h1n1-with-new-epa-registered-hard-surface-disinfectant-formulated-for-use-around-children-and-pets-67219622.html#prettyPhoto
BioTech Medical, LLC, a privately held company announced Monday that it is prepared with its new product SpectraSan 24, a new advanced surface disinfectant to immediately respond to the current Influenza A (H1N1) epidemic. BioTech Medical, LLC is a distributor for PURE Bioscience (Nasdaq: PURE), creators of the patented silver dihydrogen citrate (SDC) antimicrobial. …


 
PURE trades on the NASDAQ at $1.10+ per share:
http://finance.yahoo.com/q/pr?s=PURE+Profile
 

http://www.purebio.com/
 
These relationships are definitely something that we should keep our eye on for sure.    




 
http://bioneutral.com/Home/Page/bioneutral-group

 
Dr. Andy Kielbania, was with was Rohm and Haas which was a very huge multi-billion dollar company.  In my opinion, him being here with BONU is a huge hint that he is not here because of something that could be considered small change.  See below: 

Quote:

http://www.icis.com/v2/companies/9146143/rohm+and+haas.html

Rohm and Haas | Company Information from ICIS

In April 2009, Dow Chemical completed its $78/share takeover of Rohm and Haas. Dow Chemical will integrate its acquired Rohm and Haas business into the newly formed ‘Advanced Materials Division’ and will be headed by Pierre Brondeau.
  
 
Dow Chemical bought out Rohm and Haas for $78.00 per share.  When you click on the old Rohm and Haas website, it takes you to Dow Chemicals website:
http://www.rohmhaas.com

 
For inquiring minds, Dow Chemicals trade on the NYSE at $40.00+ per shareunder the ticker pf DOW:  
http://www.dow.com/

 
More proof that Dr. Andy Kielbania, PhD, CEO, Chief Scientific Officer and Director for BONU was an instrumental part of Rohm and Haas which was bought out by Dow Chemical:
Quote:

http://webcache.googleusercontent.com/search?q=cache:2J2TxICDbCcJ:cdn-pubs.acs.org/doi/pdfplus/10.1021/bk-1990-0427.ch007+&cd=2&hl=en&ct=clnk&gl=us
At Rohm and Haas we thank Dr. Edward Firouztale, Dr. Peter Cartier, and Dr. Andy Kielbania for scholarly discussions and assistance with the research. 



http://www.bioneutralgroup.com/management.html

 
Dr. Andy Kielbania, PhD 
The Chief Scientist with over 35 years experience in the specialty chemical field, including coatings, adhesives, personal care, biotechnology and pharmaceuticals. He has previously held positions at Rohm and Haas (do people realize how big these Companies are?) where he assumed senior level positions in research and development. In 1993, Dr. Kielbania joined National Starch and Chemical Company (part of ICI) as research and development Director. Dr. Kielbania is the inventor on 21 patents and has published many technical articles. He is the winner of awards in new technology development to improve new business opportunities and also research and development improvements. He received his PhD in organic chemistry from the University of California at Berkeley (good grief it does not get any better than that other than Harvard and MIT!) and has post doctoral experience at Stanford University





http://bioneutral.com/Home/Page/products-combinational-chemistry






 

 

Disinfectant that quickly wipes out swine flu, anthrax spores, is being tested at NJIT

http://www.nj.com/news/index.ssf/2009/11/disinfectant_that_quickly_wipe.html



http://bioneutral.com/Home/Page/products-healthcare-facilities





 

Hospital Grade Antimicrobial passed the AOAC Use Dilution test by totally eradicating all five million colony forming units of MRSA in less than one minute (fifty-nine seconds) at room temperature.
            Hospital induced Staph Infection & H1N1 Flu Virus

The required EPA testing procedures occurred at ATS Labs. 

http://ih.advfn.com/p.php?pid=nmona&cb=1255840452&article=39223080&symbol=NB^BONU




http://bioneutral.com/Home/Page/products-military-and-industrial-applications




 

BioNeutral’s Ygiene™ Kills Dangerous MRSA in Seconds. Hospital Acquired Infections (HAI’s), The big one ( staph Infection)

BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU), a specialty chemical technology based life science company, reports that its Ygiene™ Hospital Grade Antimicrobial passed the AOAC Use Dilution test by totally eradicating all five million colony forming units of MRSA in less than one minute (fifty-nine seconds) at room temperature. The required EPA testing procedures occurred at ATS Labs.

MRSA, or Methicillin-resistant Staphylococcus aureus, is a very serious health threatening microorganisms present in many health care facilities and community environments. MRSA is one of the more serious antibiotic resistant heath threatening microorganisms that contributes to Hospital Acquired Infections (HAI’s). In the U.S. alone, over two million people annually are afflicted with Hospital Acquired Infections with approximately one hundred thousand people dying. Worldwide Hospital Acquired Infections are on the rise and will lead to hundreds of thousands needless deaths annually. MRSA is also becoming a serious issue associated with Community Acquired Infections such as school and campus settings. With its power to rapidly and totally eliminate MRSA in less than one minute, BioNeutral’s Ygiene™ Hospital Grade Antimicrobial will be a significant part of the future solution for controlling Hospital Acquired Infections and Community Acquired Infections.

MORE....

http://ih.advfn.com/p.php?pid=nmona&cb=1255840452&article=39223080&symbol=NB^BONU



http://bioneutral.com/Home/Page/products-consumer-and-household





BioNeutral’s Consumer Grade Ygiene™ Delivers a 100% Total Kill on Contact of Swine Flu (H1N1) Virus – For the Home

http://ih.advfn.com/p.php?pid=nmona&cb=1251126501&article=39124372&symbol=NB^BONU



http://bioneutral.com/Home/Page/bioneutral-science-efficacy





BioNeutral Announces 100% Total Kill of Swine Flu (H1N1) on Virtual Contact of This Pandemic Causing Virus in an Independent ...

http://ih.advfn.com/p.php?pid=nmona&cb=1251126501&article=39090244&symbol=NB^BONU



http://bioneutral.com/Home/Page/bioneutral-science-safety



Swine Flu Campaign Waits on Vaccine
Only Third of Supply Is Expected for First Round of Vast Effort

By Rob Stein
Washington Post Staff Writer
Sunday, August 23, 2009

http://www.washingtonpost.com/wp-dyn/content/article/2009/08/22/AR2009082202337_pf.html
 



http://www.bioneutralstore.com/view-all-products/

VIEW ALL PRODUCTS

Sort by: 
 

 


New York Times

Monday, August 24, 2009

http://topics.nytimes.com/topics/news/business/companies/bioneutral-group-inc/index.html




http://www.slideshare.net/ProActiveNewsRoom/bioneutral-group-bonu-june-2011-powerpoint

BioNeutral Group ($BONU) - June 2011  PowerPoint

































 

BioNeutral Group Hosts Discussions with Four of the World’s Largest Health Care Companies

All Interested in Ygiene™ Sporicidal Antimicrobial Performance on Skin and Surfaces

Business Wire

Monday, August 24, 2009

http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&newsId=20090824005465&newsLang=en




CORPORATE OFFICE
211 Warren Street
Newark, NJ 07103
Phone: 973.577.8003
Fax: 973.577.8004
Email: contact@bioneutral.com


 

Daily View

 
Monthly View

 
3 Month Daily View

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BONU
Current Price
Volume:
Bid Ask Day's Range
Wiki
BONU News: Current Report Filing (8-k) 10/17/2014 03:07:26 PM
BONU News: Quarterly Report (10-q) 09/22/2014 05:06:10 PM
BONU News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 09/11/2014 02:14:41 PM
BONU News: Proxy Statement - Other Information (preliminary) (pre 14c) 08/18/2014 02:36:16 PM
BONU News: Statement of Ownership (sc 13g) 08/07/2014 02:04:27 PM
PostSubject
#17739   Michael Francis lending his own money.He is on jazzdogg 10/19/14 07:27:34 PM
#17738   No worries momoney. Hope is all we can RamTough2010 10/19/14 05:54:34 PM
#17737   So you realize they are paying 10-12% overall RamTough2010 10/19/14 05:50:27 PM
#17736   Ram, same thing here. Out of all my momoney163 10/19/14 05:22:58 PM
#17735   I read the 8k report. Has anyone seen Truth Taurus 10/19/14 04:02:37 PM
#17734   Hey Momoney, even you, in all your negativity RamTough2010 10/19/14 02:07:18 PM
#17733   TruthTaurus...maybe instead of posting hashed remarks, instead, why malt66 10/19/14 01:49:22 AM
#17732   Warning!!! Do Not Buy This Stock. This company Truth Taurus 10/18/14 09:46:26 PM
#17731   Create panic, get approval without proper testing. malt66 10/17/14 11:04:19 PM
#17730   On a Fri at 3:30, sounds like it's momoney163 10/17/14 03:47:46 PM
#17729   8-k filing --for what it's worth the game continues-- mlsses 10/17/14 03:20:41 PM
#17728   To be honest I'm half playing around on momoney163 10/16/14 06:35:25 PM
#17727   I would just like to know that it's momoney163 10/16/14 06:31:49 PM
#17726   Wow.I actually agree with a post of yours. RamTough2010 10/16/14 06:02:41 PM
#17725   lol. Ram, we should all question our investments momoney163 10/16/14 05:54:53 PM
#17724   Definition of lame. Your last post, and calling RamTough2010 10/16/14 03:12:20 PM
#17723   Now don't you go out buying it yourself momoney163 10/16/14 01:48:48 PM
#17722   I'm waiting Malt, you can't seem to point momoney163 10/16/14 11:51:18 AM
#17721   Great to see some talk on here :) HAE12 10/16/14 08:46:25 AM
#17719   Rammy...Booze, Cigarettes, good ole' home cookin...will keep the malt66 10/15/14 06:35:12 PM
#17718   Agree 100%...do on to others as one would malt66 10/15/14 04:57:31 PM
#17717   Absolutely, just do the best you can and RamTough2010 10/15/14 04:51:12 PM
#17716   No Problemo bro...the conundrum in life is that malt66 10/15/14 03:25:56 PM
#17715   Right. momoney163 10/15/14 03:05:43 PM
#17714   Hmmm , well Malt ,now there's a conundrum RamTough2010 10/15/14 03:01:12 PM
#17713   No Comment: malt66 10/15/14 02:52:56 PM
#17712   No need to. I've made my case clear malt66 10/15/14 02:50:26 PM
#17711   Seriously Malt, what makes you say this is momoney163 10/15/14 02:47:00 PM
#17710   Congrats! You solved half the riddle. malt66 10/15/14 02:10:11 PM
#17709   lol. I knew it! momoney163 10/15/14 02:09:29 PM
#17708   My name is Markus Lowenthalsky, and I'm his malt66 10/15/14 02:07:00 PM
#17707   See I think you either work for them momoney163 10/15/14 02:05:16 PM
#17706   Why do you say it's real Malt? What momoney163 10/15/14 02:01:07 PM
#17705   You are walking down a path when you malt66 10/15/14 02:00:16 PM
#17704   Oh it's real...never lay a good opportunity to malt66 10/15/14 01:39:57 PM
#17703   Ppst, it's not real. momoney163 10/15/14 11:17:56 AM
#17702   Rasta, this is ridiculous that's what kill this ero4u 10/15/14 10:04:07 AM
#17701   Lol The stock itself or the Ebola virus? Hahaha. momoney163 10/15/14 12:46:53 AM
#17700   That would be nice... thezilla85 10/14/14 05:44:18 PM
#17699   Watching for POS pump news. DoughRay 10/14/14 09:26:45 AM
#17698   Management’s plan to increase the number of authorized RastaOzMonstah 10/14/14 12:53:50 AM
#17697   Cdiff, MRSA according to infection control are level2, malt66 10/13/14 10:57:27 PM
#17696   So malt, what specifically is the malicious deception-- Use mlsses 10/13/14 10:46:25 PM
#17695   Funny how those easterners manage to live to malt66 10/13/14 10:43:48 PM
#17694   Yeah something like that. Eastern medicine has always momoney163 10/13/14 10:38:47 PM
#17693   Because it's a hoax malt66 10/13/14 10:29:36 PM
#17692   How can this p.o.s. miss out on Ebola? courtpuppy 10/13/14 10:25:14 PM
#17691   You mean a comprised immune system...by eating Mcdonalds malt66 10/13/14 08:38:24 PM
#17690   or in a body that's unbalanced. momoney163 10/13/14 07:47:24 PM
#17689   That's easy, Ebola can only survive in a malt66 10/13/14 06:12:14 PM
PostSubject